Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Enzyme Inhibition and Medicinal Chemistry|July 15, 2014
Quinolone-based HDAC inhibitorsGopalan Balasubramanian, Narasimhan Kilambi, Suresh Rathinasamy, et al.
Chemical & Pharmaceutical Bulletin|February 6, 2004
Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexesUpal Kanti Mazumder, Malaya Gupta, Subhas Somalingappa Karki, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 29, 2004
Antineoplastic and antibacterial activity of some mononuclear Ru(II) complexesUpal Kanti Mazumder, Malaya Gupta, Shiladitya Bhattacharya, et al.
Bioorganic & Medicinal Chemistry|June 29, 2005
Synthesis and pharmacological activities of some mononuclear Ru(II) complexesUpal K Mazumder, Malaya Gupta, Subhas S Karki, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 30, 2006
Synthesis and anticancer activity of certain mononuclear Ru (II) complexesSuresh Rathinasamy, Subhas Somalingappa Karki, Shiladitya Bhattacharya, et al.
Chemistry & Biodiversity|September 8, 2025
In Vitro Antioxidant and Anti-Inflammatory Activities of Seaweeds From the Bay of Bengal Coastal Region in Lipopolysaccharide-Induced RAW264.7 CellsParthasarathi Perumal, Jayaraman Vinayagam, Nazeer Ahamed Sathakkathulla, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 19, 2024
A comprehensive review on the green synthesis of silver nanoparticles from marine sourcesJanagandhan Palanisamy, Vinothkumar Suruli Palanichamy, Ganesan Vellaichamy, et al.
Frontiers in Microbiology|March 12, 2024
Padina boergesenii mediated synthesis of Se-ZnO bimetallic nanoparticles for effective anticancer activityBalaji Thirupathi, Yimtar Lanutoshi Pongen, Govindarajan Rasiravathanahalli Kaveriyappan, et al.
Scientific Reports|January 25, 2024
Green synthesis of zinc oxide nanoparticles using aqueous extract of shilajit and their anticancer activity against HeLa cellsParthasarathi Perumal, Nazeer Ahamed Sathakkathulla, Kalaivani Kumaran, et al.
International Immunopharmacology|April 2, 2013
Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effectsSantosh Vishwakarma, Lakshmi R Iyer, Milind Muley, et al.
Pageof 1